Amplia Therapeutics Limited (ATX.AX)
AUD 0.08
(-2.35%)
AUD 0.08
(-2.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -1.82 Million AUD | 74.26% |
| 2023 | -6.98 Million AUD | 44.14% |
| 2022 | -12.5 Million AUD | -576.7% |
| 2021 | -1.84 Million AUD | -66.81% |
| 2020 | -1.1 Million AUD | 9.93% |
| 2019 | -1.23 Million AUD | 44.55% |
| 2018 | -2.21 Million AUD | 61.44% |
| 2017 | -5.75 Million AUD | -80.32% |
| 2016 | -3.19 Million AUD | 21.97% |
| 2015 | -4.08 Million AUD | 48.51% |
| 2014 | -7.94 Million AUD | -50.04% |
| 2013 | -5.29 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -1.82 Million AUD | 73.9% |
| 2024 Q2 | -3.41 Million AUD | 0.0% |
| 2024 Q4 | -1.82 Million AUD | 0.0% |
| 2023 Q4 | -6.98 Million AUD | 0.0% |
| 2023 Q2 | -9.37 Million AUD | 0.0% |
| 2023 FY | -6.98 Million AUD | 44.14% |
| 2022 FY | -12.5 Million AUD | -576.7% |
| 2022 Q2 | -3.17 Million AUD | 0.0% |
| 2022 Q4 | -12.5 Million AUD | 0.0% |
| 2021 Q4 | -1.84 Million AUD | 0.0% |
| 2021 Q2 | -3.76 Million AUD | 0.0% |
| 2021 FY | -1.84 Million AUD | -66.81% |
| 2020 Q4 | -1.1 Million AUD | 0.0% |
| 2020 Q2 | -1.2 Million AUD | 0.0% |
| 2020 FY | -1.1 Million AUD | 9.93% |
| 2019 Q2 | -1.69 Million AUD | 0.0% |
| 2019 Q4 | -1.23 Million AUD | 0.0% |
| 2019 FY | -1.23 Million AUD | 44.55% |
| 2018 Q4 | -2.22 Million AUD | 0.0% |
| 2018 FY | -2.21 Million AUD | 61.44% |
| 2018 Q2 | -4.33 Million AUD | 0.0% |
| 2017 Q2 | -7.77 Million AUD | 0.0% |
| 2017 FY | -5.75 Million AUD | -80.32% |
| 2017 Q4 | -5.76 Million AUD | 0.0% |
| 2016 Q2 | -2.77 Million AUD | 0.0% |
| 2016 Q4 | -3.2 Million AUD | 0.0% |
| 2016 FY | -3.19 Million AUD | 21.97% |
| 2015 Q3 | -4.08 Million AUD | 25.87% |
| 2015 Q2 | -5.51 Million AUD | 0.0% |
| 2015 Q1 | -5.51 Million AUD | 0.0% |
| 2015 FY | -4.08 Million AUD | 48.51% |
| 2015 Q4 | -4.08 Million AUD | 0.0% |
| 2014 Q1 | -48 Thousand AUD | 0.0% |
| 2014 FY | -7.94 Million AUD | -50.04% |
| 2013 FY | -5.29 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 90.351% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -85.681% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 135.987% |
| Biome Australia Limited | -1.56 Million AUD | -16.687% |
| Patrys Limited | -2.24 Million AUD | 18.614% |
| Orthocell Limited | -19.92 Million AUD | 90.848% |
| Imugene Limited | -91.56 Million AUD | 98.008% |
| Noxopharm Limited | -2.31 Million AUD | 21.394% |
| PYC Therapeutics Limited | -65.76 Million AUD | 97.227% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | 40.269% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 82.056% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 71.163% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 70.613% |
| CSL Limited | 15.76 Billion AUD | 100.012% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 85.657% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -157.004% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 99.003% |
| Starpharma Holdings Limited | -19.83 Million AUD | 90.805% |
| Nanollose Limited | -96.22 Thousand AUD | -1795.132% |
| Memphasys Limited | 4.13 Million AUD | 144.097% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 69.733% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 63.191% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 97.701% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -47.253% |
| Race Oncology Limited | -17.18 Million AUD | 89.391% |
| Nyrada Inc. | -4.76 Million AUD | 61.765% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 98.276% |
| Dimerix Limited | -21.99 Million AUD | 91.708% |
| PharmAust Limited | -9.71 Million AUD | 81.227% |
| Immutep Limited | -122.18 Million AUD | 98.508% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 98.664% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 85.388% |
| BTC Health Limited | -2.02 Million AUD | 9.819% |
| Acrux Limited | -1.45 Million AUD | -25.075% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 89.332% |
| Biotron Limited | -386.06 Thousand AUD | -372.35% |
| Tissue Repair Ltd | -16.44 Million AUD | 88.908% |
| AdAlta Limited | -845.17 Thousand AUD | -115.765% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 90.183% |
| Hexima Limited | -2.22 Million AUD | 18.086% |
| AnteoTech Limited | -5 Million AUD | 63.539% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 89.628% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | 46.304% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 65.781% |
| Actinogen Medical Limited | -9.13 Million AUD | 80.03% |
| Immuron Limited | -11.48 Million AUD | 84.12% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 88.54% |